Comparing AI Automation Stocks: C3.ai vs. UiPath
As the enterprise AI automation landscape evolves, investors must assess the value offered by pure-play companies like C3.ai and orchestration leaders like UiPath. Here’s a breakdown of their positions.
The Case for C3.ai
- Offerings: C3.ai specializes in enterprise-grade AI applications for sectors such as defense and manufacturing. It aims to facilitate predictive analytics and generative AI on a large scale.
- Financials: In FY 2026, C3.ai reported revenues of $250.3 million, a 35.7% decrease from the previous year, along with a net loss of $470.4 million (negative net margin of -187.9%). The company is transitioning to a consumption-based pricing model to target smaller clients.
- Liquidity & Debt: C3.ai maintains a current ratio of 6.6x and has a zero debt-to-equity ratio, indicating strong liquidity despite its financial losses. However, free cash flow was a loss of $190.7 million.
The Case for UiPath
- Offerings: UiPath focuses on robotic process automation and integrates AI to optimize business workflows, serving thousands of customers including large enterprises.
- Financials: In FY 2026, UiPath achieved $1.6 billion in revenue, showing 13% year-over-year growth. The company reported a net income of $282.3 million with a net margin of 17.5%.
- Liquidity & Debt: UiPath’s current ratio is 2.5x, and it also has a zero debt-to-equity ratio. It posted a free cash flow of $352.2 million, although a large portion of that is inflated by stock-based compensation.
Risk Profile Comparison
- C3.ai: Risks include customer concentration and competition, compounded by legal scrutiny and evolving global regulations.
- UiPath: Also faces customer concentration risks and dependencies on third-party cloud services, along with challenges from rapid growth and competition with established firms like Microsoft.
Valuation Comparison
- C3.ai lacks a forward P/E ratio due to its ongoing losses, while UiPath has a forward P/E ratio of 21.4x.
- P/S Ratio: C3.ai at 5.9x vs. UiPath at 5.5x indicates similar valuations relative to sales.
Investment Recommendation
Considering growth trajectories, financial health, and future outlooks, UiPath stands out as the more appealing investment:
- Sales Growth: UiPath experienced a 17% year-over-year increase in its fiscal Q1, contrasting with C3.ai’s declining sales projections.
- Profitability: UiPath is profitable with recent net income reported, whereas C3.ai continues to struggle with losses.
In summary, while both companies are embedded within the AI automation sector, investing in UiPath is recommended due to its solid growth metrics and profitability in contrast to C3.ai’s current challenges.
